Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
- PMID: 22675071
- PMCID: PMC3394289
- DOI: 10.1093/nar/gks480
Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
Abstract
Antibodies are capable of specifically recognizing and binding antigens. Identification of the antigen-binding site, commonly dubbed paratope, is of high importance both for medical and biological applications. To date, the identification of antigen-binding regions (ABRs) relies on tools for the identification of complementarity-determining regions (CDRs). However, we have shown that up to 22% of the residues that actually bind the antigen fall outside the traditionally defined CDRs. The Paratome web server predicts the ABRs of an antibody, given its amino acid sequence or 3D structure. It is based on a set of consensus regions derived from a structural alignment of a non-redundant set of all known antibody-antigen complexes. Given a query sequence or structure, the server identifies the regions in the query antibody that correspond to the consensus ABRs. An independent set of antibody-antigen complexes was used to test the server and it was shown to correctly identify at least 94% of the antigen-binding residues. The Paratome web server is freely available at http://www.ofranlab.org/paratome/.
Figures


Similar articles
-
Structural consensus among antibodies defines the antigen binding site.PLoS Comput Biol. 2012;8(2):e1002388. doi: 10.1371/journal.pcbi.1002388. Epub 2012 Feb 23. PLoS Comput Biol. 2012. PMID: 22383868 Free PMC article.
-
Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.MAbs. 2017 Apr;9(3):419-429. doi: 10.1080/19420862.2017.1289302. Epub 2017 Feb 6. MAbs. 2017. PMID: 28165915 Free PMC article.
-
Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes.J Immunol. 2008 Nov 1;181(9):6230-5. doi: 10.4049/jimmunol.181.9.6230. J Immunol. 2008. PMID: 18941213
-
Antigen-Antibody Complexes.Subcell Biochem. 2020;94:465-497. doi: 10.1007/978-3-030-41769-7_19. Subcell Biochem. 2020. PMID: 32189312 Review.
-
Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition.J Mol Recognit. 2014 Nov;27(11):627-39. doi: 10.1002/jmr.2394. J Mol Recognit. 2014. PMID: 25277087 Review.
Cited by
-
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.MAbs. 2022 Jan-Dec;14(1):2008790. doi: 10.1080/19420862.2021.2008790. MAbs. 2022. PMID: 35293269 Free PMC article. Review.
-
Antibody Structure and Function: The Basis for Engineering Therapeutics.Antibodies (Basel). 2019 Dec 3;8(4):55. doi: 10.3390/antib8040055. Antibodies (Basel). 2019. PMID: 31816964 Free PMC article. Review.
-
SARS-CoV-2 Spike Protein Interaction Space.Int J Mol Sci. 2023 Jul 27;24(15):12058. doi: 10.3390/ijms241512058. Int J Mol Sci. 2023. PMID: 37569436 Free PMC article.
-
Quantitative Description of Surface Complementarity of Antibody-Antigen Interfaces.Front Mol Biosci. 2021 Sep 30;8:749784. doi: 10.3389/fmolb.2021.749784. eCollection 2021. Front Mol Biosci. 2021. PMID: 34660699 Free PMC article.
-
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines.Cell Rep. 2020 Mar 17;30(11):3755-3765.e7. doi: 10.1016/j.celrep.2020.02.061. Cell Rep. 2020. PMID: 32187547 Free PMC article.
References
-
- Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. 2010;10:301–316. - PubMed
-
- Verhoeyen M, Milstein C, Winter G. Reshaping human antibodies: grafting an antilysozyme activity. Science. 1988;239:1534–1536. - PubMed
-
- Almagro JC. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J. Mol. Recognit. 2004;17:132–143. - PubMed
-
- Lou J, Marks JD. Affinity maturation by chain shuffling and site directed mutagenesis. In: Kontermann F, Dübel S, editors. Antibody Engineering, Part IV. Springer Berlin Heidelberg: 2010. pp. 377–396.
-
- Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 2006;5:147–159. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources